SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK
- Conditions
- Cardiogenic Shock
- Registration Number
- NCT03313687
- Lead Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Brief Summary
International, observational registry to investigate the outcome in patients with cardiogenic shock. The primary aim of this study is to investigate the clinical outcome of patients in cardiogenic shock.
- Detailed Description
There is a focus on interventional therapies, mechanical circulatory support and new cardiovascular therapeutics in patients with cardiogenic shock (CS). The investigators will describe current practice in study sites including concomitant patients with CS. Therefore, the investigators will monitor drug therapies initiated, devices being utilized as well as outcome and side effect of possible interventions
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 2500
- Patients with cardiogenic shock treated at a tertiary care hospital.
- Age ≤17 years.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method All-cause mortality Within 30 days after admission. by registration office
- Secondary Outcome Measures
Name Time Method Ischemic events, bleeding events, heart failure, sepsis, dialysis. Within 12 months after admission. by survey, number of ischemic events, number of bleeding events, number of patients developing heart failure as well as heart failure severity (NYHA), patients developing terminal kidney failure requiring dialysis.
All-cause mortality Within 12 months after admission. by registration office
Trial Locations
- Locations (1)
University Heart Center
🇩🇪Hamburg, Germany